|
Genes | SNP | Effect | Association to cardiomyopathy | References |
Patients | Results |
|
TNFα | | Pro-inflammatory cytokines | | | [25, 26] |
−308 G/A (TNF2) TNFa2 | High TNF-a production | 42 CCC | Allele TNF2 or microsatellite TNFa2 associated with worse prognosis Shorter survival time compared with those carrying other alleles | [25] |
| | 166 CCC | No significant differences between CCC and ASY patients | [26] |
80 ASY |
| | | Lack of association of TNF polymorphisms with CCC development or to progression cardiomyopthy |
|
BAT1 | −22 C/G −348C/T | Anti-inflammatory activity associated with reduced expression of HLA-B-1 | 154 CCC 76 ASY | Homozygous −22 CC and −348 CC more frequent in CCC than in ASY Both variants are predictive of CCC evolution | [27] |
|
LTA | +80 A/C +252 A/G | Pro-inflammatory cytokines | 169 CCC 76 ASY | Homozygous +80 CC and +252 GG more frequent in CCC than in ASY Haplotype +80 C +252 G associated to CCC susceptibility | [28] |
|
TLR | TLR1 TLR2 TLR4 TLR5 TLR9 | Pathogen recognition receptors Component of innate immunity | 169 CCC 76 ASY | TLR polymorphisms did not show major risk factors for the development of CCC | [29] |
|
MAL/TIRAP | | Encodes an adaptor protein for TLR | 169 CCC 76 ASY | Heterozygous MAL/TIRAP S180L associated with lower risk of developing CCC | [29] |
|
TGFβ1 | −988 C/A −800 G/A −509 C/T 10 T/C 263 C/T | Multifunctional cytokine | 172 CCC 175 ASY 279 health control patients | −988 C/A and 263 C/T were not detected −800 A was uncommon, and −509 C/T was not associated with Chagas disease Allele C and the genotype C/C at codon 10 were associated with Chagas disease patients Allele C may be a risk factor for genetic susceptibility to Chagas disease patients | [30] |
|
MASP2 | Six SNP | Involved in the complement system | 208 Chagas disease 300 health control patients | MASP2*CD genotypes were associated risk of CCC | [31] |
|
IL-1B | IL-1B-511 IL-1F10.3 IL-1RN.4 IL-1RN 6/1 IL-1RN 6/2 | Pro-inflammatory cytokines Receptor antagonist | 58 CCC 28 ASY 50 IDC | C allele or CC genotype of the IL-1RN.4 was increased in CCC when compared with IDC and health control patients, evidencing association between this polymorphisms and CCC development | [32] |
|